COM:PARATEKPHARMA
Paratek Pharma
- Stock
Last Close
2.19
20/09 20:00
Market Cap
127.83M
Beta: -
Volume Today
4.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.69M - | -1.46M 154.25% | 1.22M 183.58% | 1.63M 33.44% | 489.50K 69.97% | -21.03M 4,396.12% | -15.32M 27.15% | 13.07M 185.29% | 12.79M 2.14% | 13.79M 7.86% | |
average payables | 707K - | 451K 36.21% | 627.50K 39.14% | 2.59M 313.07% | 3.99M 53.80% | 2.82M 29.20% | 3.10M 9.94% | 2.96M 4.46% | 3.60M 21.56% | 5.35M 48.49% | |
average receivables | 1.59M - | 3.68M 131.13% | 2.59M 29.60% | 534K 79.38% | 3.11M 481.65% | 3.07M 1.19% | 4.92M 60.18% | 12.66M 157.49% | 24.43M 92.96% | 55.58M 127.54% | |
book value per share | 45.86 - | 37.66 17.89% | 6.13 83.71% | 3.53 42.38% | 3.08 12.86% | 1.51 50.85% | -1.21 180.02% | -2.31 91.12% | -2.64 14.01% | -3.14 19.15% | |
capex per share | 0.01 - | -0.05 - | -0.03 34.32% | -0.04 22.21% | -0.00 95.43% | -0.01 282.80% | -0.01 16.78% | -0.01 9.49% | -0.00 91.41% | ||
capex to depreciation | 0.22 - | -1.20 - | -0.30 75.01% | -0.88 194.02% | 0.06 106.38% | 0.18 228.96% | -0.65 451.66% | -0.95 46.65% | -0.07 92.30% | ||
capex to operating cash flow | -0.00 - | 0.02 - | 0.01 53.16% | 0.01 93.87% | 0.00 94.80% | 0.00 141.23% | 0.00 103.90% | 0.01 112.54% | 0.00 92.96% | ||
capex to revenue | 0.01 - | -23.79 - | -0.09 99.63% | -0.00 96.04% | -0.01 312.13% | -0.01 40.19% | -0.00 64.31% | -0.00 92.26% | |||
cash per share | 44.78 - | 37.91 15.34% | 7.96 79.01% | 6.32 20.55% | 9.99 58.04% | 15.75 57.60% | 6.57 58.29% | 2.83 56.86% | 1.97 30.40% | 0.63 68.07% | |
days of inventory on hand | 1.21K - | 614.10 49.38% | 186.78 69.58% | 262.24 40.40% | |||||||
days payables outstanding | 431.21 - | 76.49 82.26% | 91.42 19.52% | 84.03 8.09% | |||||||
days sales outstanding | 610.70 - | 372.73 38.97% | 4.07K - | 170.38 95.81% | 5.31 96.88% | 211.42 3,881.89% | 131.96 37.58% | 99.94 24.27% | 188.90 89.02% | ||
debt to assets | 0.13 - | 0.29 114.15% | 0.36 25.92% | 0.76 110.95% | 1.05 37.24% | 1.43 36.13% | 1.39 2.40% | 1.50 7.68% | |||
debt to equity | 0.19 - | 0.54 181.69% | 0.72 31.56% | 4.80 570.09% | -6.62 237.87% | -2.46 62.76% | -2.00 18.79% | -1.51 24.51% | |||
dividend yield | |||||||||||
earnings yield | -0.75 - | -0.18 75.47% | -0.23 23.72% | -0.36 58.12% | -0.19 48.18% | -0.69 274.70% | -0.97 40.23% | -0.42 56.86% | -0.27 35.35% | -0.63 129.95% | |
enterprise value | 26.86M - | 6.22M 76.84% | 201.30M 3,135.71% | 297.91M 47.99% | 387.67M 30.13% | 97.79M 74.78% | 292.67M 199.30% | 423.40M 44.67% | 392.75M 7.24% | 325.87M 17.03% | |
enterprise value over ebitda | -1.25 - | -0.94 24.99% | -2.84 202.73% | -2.80 1.59% | -4.67 66.75% | -0.97 79.22% | -2.61 169.25% | -5.73 119.32% | -9.65 68.57% | -7.26 24.82% | |
ev to operating cash flow | -1.81 - | -0.34 81.48% | -3.68 996.66% | -3.17 14.00% | -4.93 55.84% | -1.20 75.59% | -2.18 81.26% | -4.09 87.50% | -8.14 98.74% | -4.93 39.44% | |
ev to sales | 15.37 - | 1.43 90.68% | 10.27K - | 30.73 99.70% | 5.71 81.41% | 17.69 209.67% | 9.73 45.00% | 3.25 66.62% | 2.16 33.45% | ||
free cash flow per share | -9.46 - | -7.33 22.51% | -3.37 54.08% | -4.68 39.06% | -2.97 36.53% | -2.58 13.22% | -4.10 58.85% | -2.35 42.62% | -1.00 57.24% | -1.22 21.10% | |
free cash flow yield | -0.40 - | -0.19 52.72% | -0.18 6.69% | -0.30 71.30% | -0.17 45.39% | -0.50 202.81% | -1.02 102.21% | -0.38 63.06% | -0.22 40.38% | -0.65 190.77% | |
graham net net | 44.01 - | 33.39 24.12% | 5.36 83.96% | 3.19 40.51% | 7.13 123.75% | 7.07 0.92% | -1.90 126.92% | -3.05 60.53% | -3.84 25.72% | -4.46 16.17% | |
graham number | 134.55 - | 77.31 42.54% | 24.35 68.51% | 20.94 14.00% | 15.17 27.55% | 11.02 27.35% | 10.35 6.12% | 11.71 13.17% | 8.51 27.29% | 9.09 6.82% | |
income quality | 0.54 - | 1.04 92.48% | 0.77 25.74% | 0.84 9.23% | 0.88 4.66% | 0.72 18.10% | 1.04 44.05% | 1.07 2.93% | 0.82 23.74% | 1.04 27.35% | |
intangibles to total assets | 0 - | 0.05 Infinity% | 0.01 70.91% | 0.01 8.98% | 0.01 56.34% | 0.00 53.44% | 0.00 19.56% | 0.00 41.97% | 0.00 3.82% | 0.00 6.57% | |
interest coverage | 364.95 - | -10.86 102.98% | -90.98 737.68% | -33.97 62.66% | -16.65 50.98% | -9.48 43.10% | -7.05 25.60% | -3.73 47.08% | -2.36 36.66% | -2.55 7.94% | |
interest debt per share | -0.05 - | 0.28 692.26% | 1.23 333.98% | 2.08 69.08% | 2.40 14.98% | 7.61 217.85% | 8.52 11.83% | 6.16 27.62% | 5.64 8.46% | 5.08 9.88% | |
inventory turnover | 0.30 - | 0.59 97.54% | 1.95 228.78% | 1.39 28.78% | |||||||
invested capital | 0.19 - | 0.54 181.69% | 0.72 31.56% | 4.80 570.09% | -6.62 237.87% | -2.46 62.76% | -2.00 18.79% | -1.51 24.51% | |||
market cap | 36.79M - | 97.48M 164.93% | 313.04M 221.14% | 311.90M 0.37% | 480.21M 53.96% | 161.66M 66.33% | 132.15M 18.26% | 276.53M 109.26% | 217.39M 21.39% | 101.71M 53.21% | |
net current asset value | 71.70M - | 86.59M 20.76% | 97.74M 12.88% | 67.96M 30.47% | 79.27M 16.64% | 2.63M 96.68% | -47.37M 1,901.90% | -115.00M 142.75% | -159.56M 38.75% | -206.74M 29.57% | |
net debt to ebitda | 0.46 - | 13.78 2,874.44% | 1.58 88.54% | 0.13 91.68% | 1.11 747.70% | 0.63 43.12% | -1.43 326.06% | -1.99 38.70% | -4.31 117.00% | -4.99 15.83% | |
net income per share | -17.54 - | -7.05 59.80% | -4.29 39.12% | -5.51 28.36% | -3.32 39.77% | -3.57 7.39% | -3.93 10.16% | -2.63 32.99% | -1.22 53.63% | -1.17 4.23% | |
operating cash flow per share | -9.47 - | -7.33 22.62% | -3.31 54.79% | -4.65 40.21% | -2.93 36.96% | -2.58 12.05% | -4.09 58.69% | -2.34 42.73% | -1.00 57.41% | -1.22 21.97% | |
payables turnover | 0.85 - | 4.77 463.72% | 3.99 16.33% | 4.34 8.80% | |||||||
receivables turnover | 0.60 - | 0.98 63.84% | 0.09 - | 2.14 2,286.08% | 68.74 3,108.84% | 1.73 97.49% | 2.77 60.22% | 3.65 32.04% | 1.93 47.09% | ||
research and ddevelopement to revenue | 3.95 - | 1.15 70.78% | 2.88K - | 4.76 99.83% | 3.36 29.44% | 2.39 28.84% | 0.55 77.01% | 0.25 54.35% | 0.25 0.05% | ||
return on tangible assets | -0.37 - | -0.17 54.11% | -0.49 188.36% | -0.83 69.14% | -0.55 34.35% | -0.38 31.43% | -0.51 37.12% | -0.66 28.34% | -0.32 51.13% | -0.37 14.69% | |
revenue per share | 1.12 - | 1.72 53.76% | 0.00 - | 0.47 32,742.68% | 0.54 15.50% | 0.50 7.12% | 0.99 95.26% | 2.50 153.59% | 2.77 10.98% | ||
roe | -0.38 - | -0.19 51.04% | -0.70 273.70% | -1.56 122.79% | -1.08 30.88% | -2.36 118.51% | 3.24 237.67% | 1.14 64.94% | 0.46 59.33% | 0.37 19.62% | |
roic | -0.42 - | -0.08 80.16% | -0.58 592.05% | -1.02 75.65% | -0.60 40.97% | -0.38 37.17% | -0.51 36.19% | -0.60 16.77% | -0.32 46.51% | -0.52 61.95% | |
sales general and administrative to revenue | 7.12 - | 1.35 81.07% | 910.34 - | 2.93 99.68% | 3.72 26.93% | ||||||
shareholders equity per share | 45.86 - | 37.66 17.89% | 6.13 83.71% | 3.53 42.38% | 3.08 12.86% | 1.51 50.85% | -1.21 180.02% | -2.31 91.12% | -2.64 14.01% | -3.14 19.15% | |
stock based compensation to revenue | 1.91 - | 0.16 91.48% | 372.14 - | 1.34 99.64% | 1.49 11.17% | 0.86 41.98% | 0.24 72.75% | 0.12 49.67% | 0.08 31.07% | ||
tangible asset value | 71.74M - | 89.58M 24.87% | 99.06M 10.58% | 69.75M 29.59% | 81.51M 16.86% | 46.75M 42.64% | -40.48M 186.58% | -103.09M 154.69% | -128.62M 24.76% | -171.87M 33.63% | |
tangible book value per share | 45.86 - | 35.43 22.75% | 6.00 83.06% | 3.44 42.63% | 3.04 11.78% | 1.48 51.17% | -1.23 183.21% | -2.33 89.06% | -2.66 13.83% | -3.16 18.96% | |
working capital | 71.70M - | 97.59M 36.11% | 121.92M 24.93% | 111.69M 8.39% | 143.70M 28.66% | 237.53M 65.30% | 219.15M 7.74% | 140.16M 36.04% | 120.80M 13.81% | 99.45M 17.67% |
All numbers in (except ratios and percentages)